Virios Therapeutics Q1 EPS $(0.08) Beats $(0.20) Estimate; Cash Balance Of $5.3M Sufficient To Support Operations Into Q2 2024

Benzinga · 05/11/2023 07:17
Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.20) by 60 percent. This is a 83.33 percent increase over losses of $(0.48) per share from the same period last year.